Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4862481
Max Phase: Preclinical
Molecular Formula: C14H13FI2N2O2
Molecular Weight: 514.08
Molecule Type: Unknown
Associated Items:
ID: ALA4862481
Max Phase: Preclinical
Molecular Formula: C14H13FI2N2O2
Molecular Weight: 514.08
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Oc1c(I)cc(I)cc1CNNC(O)c1ccc(F)cc1
Standard InChI: InChI=1S/C14H13FI2N2O2/c15-10-3-1-8(2-4-10)14(21)19-18-7-9-5-11(16)6-12(17)13(9)20/h1-6,14,18-21H,7H2
Standard InChI Key: VBPMYPNBQVTYMD-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 514.08 | Molecular Weight (Monoisotopic): 513.9051 | AlogP: 3.03 | #Rotatable Bonds: 5 |
Polar Surface Area: 64.52 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 7.19 | CX Basic pKa: 5.64 | CX LogP: 3.99 | CX LogD: 3.75 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.28 | Np Likeness Score: -0.67 |
1. Krátký M, Konečná K, Brablíková M, Janoušek J, Pflégr V, Maixnerová J, Trejtnar F, Vinšová J.. (2021) Iodinated 1,2-diacylhydrazines, benzohydrazide-hydrazones and their analogues as dual antimicrobial and cytotoxic agents., 41 [PMID:34015704] [10.1016/j.bmc.2021.116209] |
Source(1):